INVENTPRISE
Inventprise is a biotechnology company specializing in GMP vaccine product development. Its vaccine candidate is a 25-valent pneumococcal conjugate vaccine (PCV) funded by the Bill and Melinda Gates Foundation (>$100M) and aimed at large-scale supply to Low-Middle Income Countries. The company was founded in 2012 and is headquartered in Redmond, Washington.
INVENTPRISE
Industry:
Biotechnology Health Care Medical
Founded:
2012-01-01
Address:
Redmond, Washington, United States
Country:
United States
Website Url:
http://www.inventprise.com
Total Employee:
101+
Status:
Active
Contact:
(+1) 206-258-2660
Email Addresses:
[email protected]
Total Funding:
90 M USD
Technology used in webpage:
Microsoft Exchange Online Office 365 Mail Frontier Communications
Similar Organizations
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Inventprise
Official Site Inspections
http://www.inventprise.com Semrush global rank: 4.37 M Semrush visits lastest month: 2.58 K
Unable to get host informations!!!
More informations about "Inventprise" on Search Engine
About Us - Inventprise
Inventprise was founded by Subhash Kapre, PhD in 2012 to advance novel, highly impactful vaccines using proprietary technology, with the initial goal of providing lifesaving interventions globally. MEET OUR TEAM. Our mission is to empower people to live …See details»
Home - Inventprise
We are bringing a new generation of vaccines to empower people everywhere to live healthy lives. LEARN MORE We are bringing a new generation of vaccines to empower …See details»
Inventprise - Crunchbase Company Profile & Funding
Details. Inventprise is a biotechnology company specializing in GMP vaccine product development. Its vaccine candidate is a 25-valent pneumococcal conjugate vaccine …See details»
Inventprise | LinkedIn
Inventprise | 1,516 followers on LinkedIn. We address health inequalities and empower people to live healthy lives by inventing novel and affordable vaccines. | By developing …See details»
Inventprise Receives $30M, Appoints New CEO and Expands …
Redmond, WA (April 7, 2022) – Inventprise, a biotechnology company specializing in novel, affordable and highly impactful vaccines, announced today that it has received …See details»
Inventprise Announces Investment of up to $90 Million to …
Nov 10, 2021 REDMOND, Wash.-- ( BUSINESS WIRE )--Inventprise, a biotechnology company specializing in novel, affordable and highly impactful vaccines, announced …See details»
Seattle-area startup Inventprise gets backing from Gates
Nov 10, 2021 The company has grown to more than 100 employees and previously received more than $100 million from the Gates Foundation. Inventprise also provides …See details»
Inventprise Completes Vaccination of Participants in a Phase 2 …
Jan 2, 2024 About Inventprise Inc. Inventprise is a biopharmaceutical company leveraging its innovative platform technology to develop vaccines against infectious …See details»
New Inventprise Pneumococcal Vaccine Enters Phase 1/2 Clinical ...
Nov 10, 2022 Inventprise was founded by Subhash Kapre, PhD in 2012 to advance novel, affordable and highly impactful vaccines using proprietary technology, with the initial …See details»
Inventprise Inaugurates Manufacturing Facility for High-Capacity …
May 10, 2022 Inventprise is a biopharmaceutical company leveraging its innovative platform technology to develop vaccines against infectious diseases with an initial focus …See details»
Inventprise Announces Investment of up to $90 Million to …
Nov 10, 2021 Inventprise, a biotechnology company specializing in novel, affordable and highly impactful vaccines, announced today that the Bill & Melinda Gates Foundation, a …See details»
Inventprise - Gates SIF
Inventprise. Our portfolio. Next-generation pneumococcal conjugate vaccine development for LMICs. Inventprise is developing efficacious, affordable vaccines for global …See details»
Inventprise - Funding, Financials, Valuation & Investors
Inventprise is funded by Bill & Melinda Gates Foundation. Which investors participated in the most funding rounds? Show. Unlock even more features with Crunchbase Pro. Start …See details»
News & Publications - Inventprise
Inventprise Receives $30M, Appoints New CEO and Expands Corporate Board April 7, 2022 Inventprise Announces Investment of up to $90 Million to Advance its 25 Valent …See details»
Inventprise Completes Vaccination of Participants in a Phase 2 …
Jan 2, 2024 Inventprise was founded by Subhash Kapre, PhD in 2012 to advance novel, affordable and highly impactful vaccines using proprietary technology, with the initial …See details»
Inventprise Inaugurates Manufacturing Facility for High
May 10, 2022 REDMOND, Wash.-- ( BUSINESS WIRE )-- Inventprise, a biotechnology company specializing in novel, affordable and impactful vaccines, today announced the …See details»
Multi-valent pneumococcal conjugate vaccine for global health: …
Nov 30, 2022 Inventprise 25-valent pneumococcal conjugate vaccine candidate with the patented Hz-PEG-Hz linker technology platform is expected to provide the broadest …See details»
Pipeline - Inventprise
Pipeline - Inventprise. Inventprise platform technologies support a robust pipeline of novel vaccines with the potential to unlock large market opportunities with significant unmet …See details»
New Inventprise Pneumococcal Vaccine Enters Phase 1/2 Clinical ...
Nov 10, 2022 Inventprise was founded by Subhash Kapre, PhD in 2012 to advance novel, affordable and highly impactful vaccines using proprietary technology, with the initial …See details»
New Inventprise Pneumococcal Vaccine Enters Phase 1/2
Nov 10, 2022 Inventprise was founded by Subhash Kapre, PhD in 2012 to advance novel, affordable and highly impactful vaccines using proprietary technology, with the initial …See details»